Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...

A new report shows up to 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases.

In a joint venture with Novo Nordisk, Hims & Hers will dispense all doses of Wegovy to Americans who buy eligible subscriptions, with plans starting at $599 a month. The offering ...

Learn how early Alzheimer's diagnosis and new treatments transformed life for patient George Carlino and his family.

Eli Lilly has unveiled a $2.5 billion deal to acquire ... According to Lilly, STX-478 could potentially address 30%-40% of people with HR-positive breast cancer, with a profile that could allow ...

Here’s what’s coming to theaters and streaming from May to August - Hollywood is pulling out the stops this summer movie ...

Chief executive officers from Nvidia Corp., Johnson & Johnson, Eli Lilly & Co., General Electric Co. and SoftBank Group Corp.

We recently published a list of Jim Cramer’s Game Plan for This Week: 16 Stocks in Focus. In this article, we are going to ...

Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming to transform the treatment of ...

Eli Lilly partners with Creyon Bio in $13M upfront deal, potential $1B+ milestone payments. CEO Serge Messerlian leads ...